Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

SPLASH
Splash Beverage invests CDN$300,000 in cannabinoid biopharmaceutical firm Avicanna

Splash Beverage Group completed a strategic investment in Avicanna Inc., a commercial-stage cannabinoid-based biopharmaceutical company, as part of it...

FISERV
Fiserv appoints Takis Georgakopoulos as CEO with $22.5M annual compensation package

Fiserv's Board of Directors appointed Takis Georgakopoulos as Chief Executive Officer effective June 14, 2026, with total annual compensation of $22.5...

Sensei
Sensei Biotherapeutics changes corporate name to Faeth Therapeutics, Inc.

Sensei Biotherapeutics, Inc. has amended its Certificate of Incorporation to change its corporate name to Faeth Therapeutics, Inc., effective upon Del...

Neumora
Neumora discontinues navacaprant after Phase 3 failures in depression

Neumora's Phase 3 KOASTAL-2 and -3 studies of navacaprant failed to meet primary endpoints for major depressive disorder, prompting the company to hal...

Payoneer
Payoneer agrees to merger with Neon Maple Parent in all-stock transaction

Payoneer Global Inc. entered into a definitive merger agreement with Neon Maple Parent Inc. and Panda Acquisition Sub Inc. dated June 12, 2026. The tr...

TRUIST
William H. Rogers Jr. transitions to Executive Chair role at Truist Financial

William H. Rogers Jr., CEO of Truist Financial Corp, will transition to Executive Chair effective upon appointment of a new CEO, with compensation red...

Pebblebrook
Pebblebrook Hotel Trust declares Q2 2026 dividend of $0.01 per common share

Pebblebrook Hotel Trust announced quarterly cash dividends for common and preferred shares payable July 15, 2026. The declaration demonstrates continu...

Byrna
Byrna Technologies realigns sales and marketing, appoints HLK as agency of record

Byrna Technologies separated its combined sales and marketing function into two dedicated senior leadership roles and appointed HLK as its agency of r...

SEADRILL
Seadrill announces $600M senior notes offering due 2034

Seadrill Finance Limited intends to offer $600 million in senior unsecured notes to refinance existing 8.375% notes due 2030, reducing near-term debt ...

Light
Light & Wonder directors exercise vested options on cashless basis

Chairman Jamie Odell and Vice Chair Toni Korsanos notified the company of plans to exercise vested options expiring March 28, 2027 on a cashless basis...

Nano
Nano Dimension proposes to acquire Infinite Epigenics in all-stock business combination

Nano Dimension has proposed acquiring 100% of Infinite Epigenetics through a reverse merger, with Infinite shareholders receiving Nano stock based on ...

ROKU,
Roku agrees to be acquired by Fox Corporation in merger deal

Roku has entered into a definitive merger agreement with Fox Corporation, with the deal structured through two merger subsidiaries. The transaction re...

BRC
BRC Group reports $70.4M net carried interest from SpaceX IPO position

BRC Group Holdings disclosed its indirect economic interest in SpaceX following the company's June 12, 2026 IPO, with net carried interest valued at a...

JACK
Jack in the Box Funding issues $500M senior secured notes at 7.624%

Jack in the Box Funding, LLC is issuing $500 million in Series 2026-1 senior secured notes with a 7.624% fixed rate through a purchase agreement with ...

Zevia
Zevia appoints Alexandre Ruberti as CEO; revises Q2 2026 guidance upward

Zevia PBC appointed seasoned beverage executive Alexandre Ruberti as President and CEO effective immediately, replacing Amy Taylor who is joining Ange...

Enhanced
Enhanced Group Inc. issues warrant to purchase common stock at set exercise price

Enhanced Group Inc. issued a form warrant allowing holders to purchase Class A common stock at a specified exercise price through 2031. The unregister...

Fox
Fox to acquire Roku for $22B in cash and stock deal

Fox Corporation agreed to acquire Roku for $160 per share, creating a scaled media and technology platform combining Fox's live content with Roku's st...

Alkermes
Alkermes obtains orphan drug designations for alixorexton in US and EU

Alkermes announced that its investigational narcolepsy and idiopathic hypersomnia treatment alixorexton received orphan drug designations from the FDA...

Canopy
Canopy Growth reports Q4 FY2026 net revenue growth of 10%, driven by cannabis segment expansion

Canopy Growth delivered consolidated net revenue of $71.2M in Q4 FY2026 (up 10% YoY) and $284.6M for full-year 2026 (up 6% YoY), with cannabis revenue...

Lexeo
Lexeo Therapeutics finalizes SUNRISE-FA 2 pivotal trial design for LX2006 gene therapy

Lexeo Therapeutics announced finalization of the SUNRISE-FA 2 pivotal trial protocol for LX2006 in Friedreich ataxia, with first patient enrollment ex...